Navigation Links
Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer
Date:1/18/2008

AUSTIN, Texas, Jan. 18 /PRNewswire/ -- Joined by New York City Mayor Michael Bloomberg, Lance Armstrong and immediate past Surgeon General Dr. Richard Carmona today discussed Lance's request to the Surgeons General Collective to create a national strategy to combat cancer.

"This year alone, 1.4 million Americans are expected to be diagnosed with cancer and 560,000 will likely lose their lives to the disease," said Lance Armstrong, founder and chairman of the Lance Armstrong Foundation (LAF). "Cancer has become an epidemic that touches every single American life and costs our economy over $300 billion every year. The time has come to move aggressively against this foe and that is why I have asked Dr. Carmona to lead the Surgeons General Collective in forming a national strategy to fight cancer. This strategy will serve as a roadmap for the American people and our leaders, including the next President, to save millions of lives by improving access to care and focusing on cancer prevention and survivorship."

Richard Carmona, M.D., M.P.H., FACS, 17th Surgeon General of the United States (2002-2006) and President of Canyon Ranch Institute, formed the Surgeons General Collective, an independent body composed of the previous Surgeons General of the United States, in October 2007 to address national and global public health issues. At Lance's request, the first major public health issue this independent scientific body will take up is to develop a national call to action focused on cancer prevention and survivorship.

"Despite earnest efforts in the medical and research community, government and advocacy groups, and many concerned citizens, we have yet to achieve the level of momentum and national coordination necessary to win the war against cancer," said Dr. Carmona. "The need and the urgency to make cancer prevention and survivorship a national priority should be clear to all of us, but the level of action and progress is not nearly what it sho
'/>"/>

SOURCE Lance Armstrong Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. U.S. Food Safety: Solutions at a Glance
2. Physical Therapist Intervention for Balance Impairments May Help Reduce Risk of Falling
3. Smart Balance Announces Conversion of Convertible Preferred Stock
4. Evolution Tips the Balance in Moms Favor
5. Researchers led by Penn vet uncover the delicate protein balance behind the immune system response
6. Lance Armstrong Foundation Awards $1.5 Million in Grants
7. 10 Cities to Participate in Live Well! Life Beyond Cancer Program Sponsored by The Wellness Community and the Lance Armstrong Foundation
8. New Lancet Study: Tobacco Control Measures Are Effective and Affordable Strategies to Reduce Chronic Disease Deaths Globally
9. Complementary medicines training provides balance, not bias
10. Smart Balance Announces Third Quarter 2007 Results
11. MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)... Output of New Molecular Entities Drops to Histori... Competition from Generics Companies, LONDON, Jul...omson,Reuters today announced the availability of ...eutical R&D Factbook, an indispensable reference,a...harmaceutical R&D,corporate finance, business str...
(Date:7/23/2008)... WINSTON-SALEM, N.C. A study out of Wake Forest ...rgency room doctors are correctly identifying pati...ratory tests haven,t yet confirmed it. , The stu...nalyzed patients with heart attack symptoms who we...t participating U.S. centers. , The findings we...
(Date:7/23/2008)... NASDAQ: CRME, TSX: COM, VANCOUVER, July 23 /...DAQ: CRME/TSX: COM) today announced that it has en...nts, LLC, an investment fund managed by,CR Intrins...Advisors, LLC,to purchase Series A convertible pre... Proceeds of the financing will be used for genera...
(Date:7/23/2008)... HOUSTON, July 23 /PRNewswire-FirstCall/ -- The... property and casualty company, today announced it...urricane Dolly, which is,sweeping through southern...-bin/prnh/20051031/NEM023LOGO ), "We are deeply ...y,s,path," said Robin A. Nicks, president of The H...
Breaking Medicine News(10 mins):Health News:Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online 2Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:The Hanover Ready to Serve Policyholders Impacted by Hurricane Dolly 2
...d at gauging adolescent health, has said that thos...riage, show a propensity to cover //the truth abou...so rigid about maintaining their virginity. The s...l encounters among students between seventh to twe...
...r Dr Kebede Worku has said that there has been a s...in the country. The prevalence rate is 5 percent//...due to their low socio-economic status in Ethiopia... he said. 'The national surveillance report estima...
...below 65 years, a government job in Assam is assur...t the appointment letter on the spot//. But there ... rural areas. 'Anybody with a medical degree can ...ew on Wednesday and Thursday and get a job. We hav...
... in the June issue of the journal Obstetrics & Gyn...at engaging in sexual intercourse during the final...very//. The study conducted by the Ohio state Uni... belief and states that just the opposite was true...
Other Medicine News:Health News:Assam Recruits Doctors to Serve in Rural Areas 2Health News:A New Study Discredits The Myth Of Sexual Intercourse Late In Pregnancy Speeds Labour & Delivery 2
(Date:7/22/2008)...nt Plan Completed Successfully, DUBLIN, Ireland, ...on,plc (NASDAQ: AMRN ) today announced that the C...d and Drug Administration (FDA) to discuss the,Com...f,hypertriglyceridemia. Following these discussion...1 in hypertriglyceridemia., Dr. Declan Doogan, He...
(Date:7/22/2008)...2 /- Hyperion,Therapeutics, Inc. toda...nt,in its Phase 1/2 clinical trial to evaluate the...ts of HPN-100 (formally called GT4P) versus,BUPHEN...a cycle disorders,(UCD). The company plans to anno...s year., (Logo: http://www.newscom.com/cgi-bin/p...
(Date:7/22/2008)...etic Risk Based on Clinical Data, Preventive Me...s, WALTHAM, Mass., July 22 /PRNewswire-FirstCall/...y announced the launch of an enhanced test report,...eart Health Genetic Test.,The test is currently ma...h,Genetic Test by Quixtar/Amway. The new report wi...
(Date:7/21/2008)... SEAS (Simvastatin and Ezetimibe in,Aortic Stenosi...,cholesterol lowering with the combination of simv...in patients with aortic stenosis., Aortic stenosi...alve in,the heart) is a relatively common disease ...treated, it can progress to death from heart failu...
Breaking Medicine Technology:Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4Popular Florida Restaurant Leads Hospitality Industry by Converting to Pasteurized Shell Eggs Usage 11283 1Popular Florida Restaurant Leads Hospitality Industry by Converting to Pasteurized Shell Eggs Usage 11283 2EBRI Policy Forum 3A Large Employers Continue to Offer Health Benefits 11281 1EBRI Policy Forum 3A Large Employers Continue to Offer Health Benefits 11281 2Elderly more likely to deny smoking when asked says Case Western Reserve University researcher 11277 1Elderly more likely to deny smoking when asked says Case Western Reserve University researcher 11277 2Shengtai Pharmaceutical Inc to Present at Roth Conference 11273 1Shengtai Pharmaceutical Inc to Present at Roth Conference 11273 2Shengtai Pharmaceutical Inc to Present at Roth Conference 11273 3
...ILEA, Hawaii and SUNNYVALE, Calif., June 27, 2007,...y announced,preliminary results from two open-labe... the potential use of Xcytrin(R),(motexafin gadoli...ate, in combination with Alimta(R) (pemetrexed) an... second-line treatment,for patients with non-small...
...S, the Netherlands, June 27, 2007-Organon, the hum...ed today that two,out of three Phase III clinical ...w long-acting fertility hormone, have reached,thei...s a new recombinant fertility hormone. It is,the f...follicular,stimulant or SFS) of which, due to its ...
Other Medicine Technology:Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 2Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 3Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 4Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 5Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 2Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 3
Electrical I/A unit for planned ECCE with peristaltic pump with linear aspiration (foot control). Independent irrigation, suction, reflux possible with multi-function footswitch that allows the surge
Globe Fixation Ring
To enter, dissect, elevate and smooth the flap. Combined features of Spatula, Dissector and Forceps. - Also available in Titanium
The CGAL gonioscopic contact glass was designed by Roussel and Fankhauser for,laser treatments of the chamber angle. It reduces the laser spot by a factor of 1.5 as compared to a Goldmann Glass.
Medicine Products: